2NA FISH: Revolutionizing Cancer Diagnostics with RNA & AI

New and often costly cancer treatments are being developed constantly – yet for many patients with advanced solid tumors, outcomes remain frustratingly limited. According to the world-renowned cancer researcher and author, Dr. Azra Raza, the overall success rate of such treatments hasn’t improved significantly since the 1930s.

In this session, Dr. Christina Port, CEO of 2NA FISH, explains why the future of personalized cancer care begins not with treatment, but with better diagnostics. She’ll present how her team is using RNA analysis and cutting-edge AI to radically improve diagnostic precision — aiming to match the right therapy to the right patient, at the right time. Join us to discover how intelligent diagnostics could unlock a new era in oncology.